GLP-1s, fertility, & Ozempic vagina: what nobody is telling you.
- Dr. Sarah Bentolila, DAIM,L.Ac
- 11 minutes ago
- 8 min read
Ozempic, semaglutides and GLP1s are in every conversation right now. My patients bring it up constantly, either because they are on it, their doctor suggested it, their friend lost 40 pounds on it, or they read something on Reddit that scared them.
It is one of the most searched health topics in the country, and the fertility angle specifically has exploded in the past year with the "Ozempic baby boom" headlines and, more recently, the "Ozempic vagina" conversation.
I want to give you a clear, honest picture of what the research actually shows, where the genuine concerns are, and where Chinese medicine fits in for patients who are trying to conceive.
I am not going to tell you GLP-1 medications are evil. I am also not going to tell you they are a fertility treatment. The truth is more nuanced .
What GLP-1 medications are and what they do
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and others, were originally developed for type 2 diabetes management.
They work by mimicking glucagon-like peptide-1, a hormone that regulates blood sugar, delays gastric emptying, and suppresses appetite. The weight loss that results from this is significant and in many cases clinically meaningful.
They are not fertility drugs. That distinction matters and gets lost in the social media conversation about Ozempic babies and surprise pregnancies.
Where GLP-1s genuinely help fertility
Metabolic conditions like PMOS
For a specific population, GLP-1 medications can improve fertility-adjacent outcomes.
Specifically, women with
insulin-resistant PCOS
obesity-related anovulation
metabolic syndrome where weight and insulin resistance are directly driving the cycle disruption.
Here is the mechanism: elevated insulin and insulin resistance disrupt the HPO axis, drive androgen excess, and suppress ovulation. Weight loss improves insulin sensitivity, which can restore ovulatory frequency.
This is why some women with PCOS or obesity-related infertility have conceived after starting Ozempic. It is not that the drug is acting as a fertility treatment. It is that improving metabolic health removed a specific obstacle to ovulation.
Moreover, acupuncture and chinese herbs are extremely efficient at restoring ovulation in PMOS women (read article here).
Some research
A 2025 review of 12 small trials found modest improvements in natural conception rates in women with PCOS and metabolic dysfunction using GLP-1 medications. A separate meta-analysis found improvements in menstrual cycle regularity and ovulation rates in PCOS patients. These are real findings worth taking seriously.
Emerging research has also identified GLP-1 receptors directly inside human ovarian cells, suggesting the medications may influence egg development more directly than previously thought. The clinical significance of this is not yet established.
For male fertility
Some data suggest GLP-1 medications may improve sperm quality in men with obesity or metabolic dysfunction, through improvements in testosterone and the hormonal environment of spermatogenesis.
A 2024 paper published in Frontiers in Physiology reviewing the existing evidence called this a "fable of caution," noting that while metabolic improvement theoretically benefits sperm, the direct effects of GLP-1 receptor activation on sperm function remain largely unexplored and some prior GLP-1 agents showed concerning signals in animal studies.
Where I have concerns for fertility patients
This is where I want to be direct with you, because this is what the blog posts and the headlines are not saying clearly enough.
You must stop GLP-1 medications before trying to conceive.
This is not my opinion. It is the FDA recommendation and the position of every major reproductive medicine body.
The FDA recommends discontinuing GLP-1 receptor agonists at least two months before attempting pregnancy.
Semaglutide has a long half-life and takes time to clear the system.
The safety data on GLP-1 exposure during pregnancy is not reassuring:
a 2024 observational study published in BMJ Open examining GLP-1 use in early pregnancy found no definitive safety signal but the data is preliminary, the cohort sizes are limited, and the FDA has not approved these medications for use during pregnancy.
This means if you are planning an IVF retrieval or a natural conception attempt in the next two to three months, you need to have a direct conversation with whoever prescribed the GLP-1 medication about stopping it now.
Rapid weight loss depletes the resources that fertility depends on.
In Chinese medicine, fertility is governed by kidney jing and blood.
These are the constitutional resources that build eggs, nourish the uterine lining, produce cervical mucus, and sustain early pregnancy. They take time to build and they are depleted by significant physiological stress, including rapid weight loss.
Losing 20 to 40 pounds in four to six months is a significant physiological stress on the body's yin and blood resources, regardless of how healthy the end metabolic state is.
I see this clinically: patients who have undergone rapid weight loss on GLP-1 medications and then come in to start fertility treatment often present with blood deficiency and yin deficiency patterns, thin lining, poor cervical mucus, and a cycle that is technically ovulating but not thriving.
The metabolic picture may improve but the reproductive building blocks have been depleted in the process.
The right sequence for a PCOS patient with insulin resistance who wants to use a GLP-1 medication is:
use the medication to achieve metabolic stability
allow two to three months of nutritional rebuilding before attempting conception
support the reproductive system with acupuncture and herbal medicine during that rebuilding period
and only then pursue conception with the full biological picture in the best possible state.
The egg quality question is not settled.
Several patients have asked me whether Ozempic improves egg quality directly. The honest answer is that there are no human studies demonstrating direct egg quality improvement from GLP-1 medications.
What exists is indirect evidence
Improving the metabolic environment may improve the conditions in which eggs develop. That is different from the medication acting on egg quality directly.
Dr. Natalie Crawford, a reproductive endocrinologist who has reviewed the evidence carefully, put it clearly:
"We do not currently have human studies showing that GLP-1 medications directly improve egg quality."
For patients with both metabolic dysfunction and poor egg quality history, improving metabolic health is worth pursuing. But it is not a substitute for the direct mechanisms acupuncture and herbal medicine work on: ovarian blood flow, oxidative stress reduction in the follicular environment, and hormonal regulation of the follicular development timeline.
GLP-1 medications do not improve IVF outcomes
This is the finding that is most relevant for my IVF patients.
The same 2025 review that found modest improvements in natural conception rates found no improvement in IVF outcomes in women using GLP-1 medications. This makes clinical sense: IVF bypasses ovulation as a requirement, so the benefit of restored ovulation from metabolic improvement is not the relevant variable.
What matters for IVF is egg quality, embryo quality, and implantation environment, and GLP-1 medications do not have established direct effects on any of these.
If you are pursuing IVF and someone has suggested GLP-1 medications as part of your protocol, the question to ask your RE is: what specific outcome are we expecting this to improve, and what does the evidence show for that outcome in IVF patients specifically?
Ozempic vagina: what is actually happening
"Ozempic vagina" or "Ozempic vulva" is not a listed side effect of GLP-1 medications, but it is a real phenomenon that women on these drugs are reporting in large numbers.
The primary presentations are:
sagging or deflation of the outer labia
vaginal dryness
reduced sensation
pain with intercourse
pelvic floor weakness.
recurring BV or yeast infections
Here is what is driving each of these:
Fat pad loss
The vulva and labia contain fat pads that provide cushioning, structural support, and contribute to the appearance of the vulvar area. Rapid and significant weight loss depletes fat pads throughout the body, including in the vulva. This produces the sagging and deflation that women are describing.
This is not a direct effect of the semaglutide molecule. It is an effect of rapid fat loss from any source. The rate of weight loss on GLP-1 medications amplifies it.
Vaginal dryness and atrophy
This one is more complex. Several mechanisms are likely contributing.
Estrogen levels can drop with significant weight loss because adipose tissue is a source of estrogen conversion. Lower circulating estrogen produces the same vaginal atrophy picture as perimenopause: thinner vaginal walls, reduced lubrication, and dyspareunia.
GLP-1 medications may also cause dehydration through their gastrointestinal effects, which compounds vaginal dryness. A case report published in a peer-reviewed journal described female anorgasmia and reduced genital arousal in a patient on semaglutide, proposing smooth muscle vasoconstriction with reduced genital blood flow as a possible mechanism.
Pelvic floor changes
Rapid weight loss reduces the mechanical load that the pelvic floor had been supporting. This sounds like it should be a good thing, but in practice it can produce a loss of pelvic floor tone and coordination as the muscles adapt to a changed load environment.
Women who lose significant weight quickly without specific pelvic floor rehabilitation sometimes notice symptoms of pelvic floor dysfunction.
Recurring infections
BV and or yeast infections that won't go away are created by all the above conditions There is a direct connection between the microbiome in your gut and in your vagina, and the use of GLP-1 severely impacts both. Combined with dehydration, it creates a perfect storm for bacteria and fungus to overgrow.
What to do about it
stay well hydrated throughout GLP-1 treatment.
Use a pH-balanced vaginal moisturizer daily, not just lubricant during intercourse but a daily maintenance moisturizer.
If vaginal dryness is significant, discuss topical estrogen with your OB or gynecologist.
Work with a pelvic floor physical therapist if you are experiencing pelvic floor changes.
And come in for acupuncture, because the vaginal dryness and atrophy picture is exactly the kidney yin deficiency pattern that Chinese herbal medicine addresses directly and effectively.
Where Chinese medicine fits in for GLP-1 patients
If you are on a GLP-1 medication, have recently stopped one, or are considering one while trying to conceive, here is what acupuncture and Chinese herbal medicine address that the medication does not.
Blood and yin rebuilding after rapid weight loss
The herbs that nourish kidney yin, build blood, and restore the richness of the reproductive building blocks are exactly what a body depleted by rapid weight loss needs before attempting conception. This is the most common presentation I see in GLP-1 patients coming in for fertility: metabolically improved, but reproductively depleted.
Uterine lining support
Even with restored ovulation, a body that has undergone rapid weight loss may have thinner lining than expected. Acupuncture's documented effects on uterine blood flow directly address this.
Vaginal health
The vaginal dryness and atrophy picture from GLP-1 rapid weight loss is a yin deficiency presentation in Chinese medicine. Herbal formulas that nourish kidney yin and the essence of the reproductive tract, combined with appropriate topical moisturizing and possibly topical estrogen where indicated, produce consistent improvement.
Cervical mucus restoration
Adequate fertile-quality cervical mucus requires estrogen and yin fluids. After rapid weight loss and yin depletion, cervical mucus is often the last reproductive parameter to recover. Herbal medicine supports its return.
Ongoing cycle regulation
For PCOS patients who used a GLP-1 medication to restore ovulation and then stopped it before conception, the cycle may not maintain regular ovulation without the medication. Acupuncture and herbal medicine support the continuation of ovulatory function after the metabolic stabilization the medication achieved.
My honest take
GLP-1 medications are a meaningful tool for a specific population. If you have insulin-resistant PCOS, obesity-related anovulation, or significant metabolic dysfunction that is directly preventing ovulation, these medications can be genuinely useful as part of a sequence.
GLP-1s are not a shortcut to better eggs. They are not a substitute for the 90-day preparation window. They are not safe to use during an active conception attempt or pregnancy. And the rapid weight loss they produce comes with reproductive consequences that need active support, not just the assumption that thinner automatically means more fertile.
If you are navigating this and you are in the Pasadena area, come in. The combination of metabolic improvement from the medication and reproductive rebuilding through Chinese medicine is a coherent and well-sequenced approach. I am happy to work alongside whatever your RE or prescribing doctor has recommended. You can book a new patient appointment here or call us at 626-841-2991.
For the full picture on PCOS and how we approach treatment for each subtype, the PCOS guide covers the metabolic, lean, adrenal, and post-pill presentations in detail. And for women experiencing vaginal dryness and pelvic changes, the women's health page covers how we treat the full spectrum of vulvovaginal and hormonal presentations.
Comments